FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.3442
+0.0306 (9.76%)
At close: May 20, 2025, 4:00 PM
0.3401
-0.0041 (-1.19%)
After-hours: May 20, 2025, 7:59 PM EDT
FibroGen Market Cap
FibroGen has a market cap or net worth of $34.78 million as of May 20, 2025. Its market cap has decreased by -68.84% in one year.
Market Cap
34.78M
Enterprise Value
92.39M
1-Year Change
-68.84%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $34.78M, a decrease of -97.16%. That is a compound annual growth rate of -28.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 31.70M | -40.53% |
| Dec 31, 2024 | 53.30M | -38.81% |
| Dec 29, 2023 | 87.10M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.28B |
| Johnson & Johnson | 366.32B |
| AbbVie | 325.57B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 278.08B |
| Abbott Laboratories | 235.10B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |